Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Slifker

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Frontiers in Oncology|March 30, 2019
Disease Control With FOLFIRI Plus Ziv-aflibercept (zFOLFIRI) Beyond FOLFIRI Plus Bevacizumab: Case Series in Metastatic Colorectal Cancer (mCRC)Wafik S El-Deiry, Arthur Winer, Michael Slifker, et al.
Cancer Prevention Research (Philadelphia, Pa.)|December 7, 2011
ALDH1A1 is a novel EZH2 target gene in epithelial ovarian cancer identified by genome-wide approachesHua Li, Benjamin G Bitler, Vinod Vathipadiekal, et al.
Cancer Research Communications|June 28, 2023
Integrative Metatranscriptomic Analysis Reveals Disease-specific Microbiome-host Interactions in Oral Squamous Cell CarcinomaVinay Jain, Divyashri Baraniya, Doaa E El-Hadedy, et al.
The Oncologist|November 19, 2020
Molecular Profiling of Exceptional Responders to Cancer TherapyMarijo Bilusic, Daniel Girardi, Yan Zhou, et al.
Plos Pathogens|December 19, 2014
Cellular oxidative stress response controls the antiviral and apoptotic programs in dengue virus-infected dendritic cellsDavid Olagnier, Suraj Peri, Courtney Steel, et al.
Oncotarget|October 15, 2016
Reduced PAK1 activity sensitizes FA/BRCA-proficient breast cancer cells to PARP inhibitionOlga Villamar Cruz, Tatiana Y Prudnikova, Daniela Araiza-Olivera, et al.
Oncotarget|November 23, 2017
<i>Thymine DNA Glycosylase (TDG)</i> is involved in the pathogenesis of intestinal tumors with reduced <i>APC</i> expressionJinfei Xu, Salvatore Cortellino, Rossella Tricarico, et al.
In Vitro Cellular & Developmental Biology. Animal|November 22, 2014
Oxidized derivative of docosahexaenoic acid preferentially inhibit cell proliferation in triple negative over luminal breast cancer cellsThomas J Pogash, Karam El-Bayoumy, Shantu Amin, et al.
Oncotarget|June 8, 2017
BRCA2, EGFR, and NTRK mutations in mismatch repair-deficient colorectal cancers with MSH2 or MLH1 mutationsSafoora Deihimi, Avital Lev, Michael Slifker, et al.
International Journal of Molecular Sciences|February 21, 2020
Genetic Variants Detected Using Cell-Free DNA from Blood and Tumor Samples in Patients with Inflammatory Breast CancerJennifer S Winn, Zachary Hasse, Michael Slifker, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Frontiers in Oncology|March 30, 2019
Disease Control With FOLFIRI Plus Ziv-aflibercept (zFOLFIRI) Beyond FOLFIRI Plus Bevacizumab: Case Series in Metastatic Colorectal Cancer (mCRC)Wafik S El-Deiry, Arthur Winer, Michael Slifker, et al.
Cancer Prevention Research (Philadelphia, Pa.)|December 7, 2011
ALDH1A1 is a novel EZH2 target gene in epithelial ovarian cancer identified by genome-wide approachesHua Li, Benjamin G Bitler, Vinod Vathipadiekal, et al.
Cancer Research Communications|June 28, 2023
Integrative Metatranscriptomic Analysis Reveals Disease-specific Microbiome-host Interactions in Oral Squamous Cell CarcinomaVinay Jain, Divyashri Baraniya, Doaa E El-Hadedy, et al.
The Oncologist|November 19, 2020
Molecular Profiling of Exceptional Responders to Cancer TherapyMarijo Bilusic, Daniel Girardi, Yan Zhou, et al.
Plos Pathogens|December 19, 2014
Cellular oxidative stress response controls the antiviral and apoptotic programs in dengue virus-infected dendritic cellsDavid Olagnier, Suraj Peri, Courtney Steel, et al.
Oncotarget|October 15, 2016
Reduced PAK1 activity sensitizes FA/BRCA-proficient breast cancer cells to PARP inhibitionOlga Villamar Cruz, Tatiana Y Prudnikova, Daniela Araiza-Olivera, et al.
Oncotarget|November 23, 2017
<i>Thymine DNA Glycosylase (TDG)</i> is involved in the pathogenesis of intestinal tumors with reduced <i>APC</i> expressionJinfei Xu, Salvatore Cortellino, Rossella Tricarico, et al.
In Vitro Cellular & Developmental Biology. Animal|November 22, 2014
Oxidized derivative of docosahexaenoic acid preferentially inhibit cell proliferation in triple negative over luminal breast cancer cellsThomas J Pogash, Karam El-Bayoumy, Shantu Amin, et al.
Oncotarget|June 8, 2017
BRCA2, EGFR, and NTRK mutations in mismatch repair-deficient colorectal cancers with MSH2 or MLH1 mutationsSafoora Deihimi, Avital Lev, Michael Slifker, et al.
International Journal of Molecular Sciences|February 21, 2020
Genetic Variants Detected Using Cell-Free DNA from Blood and Tumor Samples in Patients with Inflammatory Breast CancerJennifer S Winn, Zachary Hasse, Michael Slifker, et al.
Pageof 4